Back to User profile » Dr Michael Bogart

Papers published by Dr Michael Bogart:

Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation

Mannino D, Bogart M, Germain G, Huang SP, Ismaila AS, Laliberté F, Jung Y, MacKnight SD, Stiegler MA, Duh MS

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:491-504

Published Date: 5 March 2022

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

Silver J, Bogart M, Packnett E, Wu J, McMorrow D, Hahn B

Journal of Asthma and Allergy 2020, 13:689-699

Published Date: 16 December 2020

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs

Llanos JP, Ortega H, Bogart M, Packnett ER, Manjelievskaia J, Bell CF, Hahn B

Journal of Asthma and Allergy 2020, 13:77-87

Published Date: 29 January 2020

Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost

Maeng DD, Graham J, Bogart M, Hao J, Wright EA

ClinicoEconomics and Outcomes Research 2018, 10:551-562

Published Date: 24 September 2018